Neurocysticercosis: a review (Q24606075)

23 March 2019

25 April 2019

6 August 2019

12 September 2019

22 October 2019

27 May 2020

5 August 2020

Current consensus guidelines for treatment of neurocysticercosis

29 April 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

A diagnostic and therapeutic scheme for a solitary cysticercus granuloma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Proposed diagnostic criteria for neurocysticercosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Public health implications of cysticercosis acquired in the United States

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Neurocysticercosis, a persisting health problem in Mexico

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Cysticercosis and neurocysticercosis as pathogens affecting the nervous system

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Morphology and biochemistry of the pork tapeworm, Taenia solium

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Changing trends in ocular cysticercosis over two decades: an analysis of 118 surgically excised cysts

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Treatment of neurocysticercosis: current status and future research needs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Role of chemotherapy of taeniasis in prevention of neurocysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Transmission dynamics of Taenia solium and potential for pig-to-pig transmission.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Neurocysticercosis: updated concepts about an old disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

New concepts in the diagnosis and management of neurocysticercosis (Taenia solium).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Calcific neurocysticercosis and epileptogenesis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Imaging findings in neurocysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Neurocysticercosis and oncogenesis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Treating neurocysticercosis medically: a systematic review of randomized, controlled trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Intraventricular cysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Neurocysticercosis: changes after 25 years of medical therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Therapy of parenchymal brain cysticercosis with praziquantel.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Epilepsy due to neurocysticercosis: analysis of 203 patients.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador.

30 May 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Neurocysticercosis in Houston, Texas: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Neurocysticercosis among patients with cerebral gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F159821

A descriptive study of neurocysticercosis in a tertiary care hospital

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Spinal neurocysticercosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261519

Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú

28 November 2018

1 reference

12 December 2020

Cysticercotic encephalitis: a severe form in young females

1 reference

12 December 2020

Albendazole therapy for neurocysticercosis

1 reference

12 December 2020

Intrasellar cysticercosis

1 reference

12 December 2020

Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel

1 reference

12 December 2020

An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium)

1 reference

12 December 2020

Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis

1 reference

12 December 2020

1 reference

12 December 2020